Henry D J, Hu X T, White F J
Department of Cellular and Molecular Pharmacology, Finch University of Health Sciences, The Chicago Medical School, North Chicago, IL 60064-3095, USA.
Psychopharmacology (Berl). 1998 Nov;140(2):233-42. doi: 10.1007/s002130050762.
The mesoaccumbens dopamine (DA) system is intricately involved in sensitization to the locomotor stimulant effects of cocaine. Among the adaptations implicated in cocaine sensitization are transient subsensitivity of impulse-regulating DA D2 autoreceptors on ventral tegmental area (VTA) DA neurons leading to hyperactivity of the mesoaccumbens DA pathway, and persistently enhanced DA D1 receptor responses of nucleus accumbens (NAc) neurons. We have tested the hypothesis that both of these adaptations are necessary to produce cocaine sensitization. We injected rats twice daily for 2 weeks with the selective DA D1 class receptor agonist SKF 38393, the DA D2 class receptor agonist quinpirole, or both. We then used single-cell recording procedures to determine possible alterations in VTA DA autoreceptor sensitivity and NAc D1 receptor sensitivity at three withdrawal times: 1 day, 1 week and 1 month. We also tested whether these treatments produced cross-sensitization to cocaine at each withdrawal time. Repeated quinpirole treatment produced a reduction in VTA autoreceptor sensitivity and cross-sensitization to cocaine, but these effects lasted for less than 1 week. Repeated SKF 38393 treatment produced enhanced NAc D1 responses which lasted for 1 week and cross-sensitization to cocaine which was only evident after 1 week of withdrawal. Repeated treatment with the combination of the two agonists transiently down-regulated autoreceptor sensitivity, enhanced and prolonged D1 receptor supersensitivity (lasting 1 month), and produced enduring cross-sensitization to cocaine. These results suggest that neuroadaptations within both the VTA and NAc may be necessary for the induction of enduring cocaine sensitization.
中脑伏隔核多巴胺(DA)系统与对可卡因运动兴奋作用的敏化密切相关。与可卡因敏化相关的适应性变化包括腹侧被盖区(VTA)DA神经元上调节冲动的DA D2自身受体的短暂亚敏感性,导致中脑伏隔核DA通路活动亢进,以及伏隔核(NAc)神经元的DA D1受体反应持续增强。我们检验了这样一种假设,即这两种适应性变化对于产生可卡因敏化都是必要的。我们每天给大鼠注射两次,持续2周,注射选择性DA D1类受体激动剂SKF 38393、DA D2类受体激动剂喹吡罗,或两者同时注射。然后,我们使用单细胞记录程序来确定在三个撤药时间点(1天、1周和1个月)VTA DA自身受体敏感性和NAc D1受体敏感性可能发生的变化。我们还测试了这些处理在每个撤药时间点是否对可卡因产生交叉敏化。重复给予喹吡罗治疗可降低VTA自身受体敏感性并对可卡因产生交叉敏化,但这些作用持续不到1周。重复给予SKF 38393治疗可增强NAc D1反应,持续1周,并对可卡因产生交叉敏化,这仅在撤药1周后才明显。两种激动剂联合重复治疗可短暂下调自身受体敏感性,增强并延长D1受体超敏感性(持续1个月),并对可卡因产生持久的交叉敏化。这些结果表明,VTA和NAc内的神经适应性变化可能是诱导持久可卡因敏化所必需的。